NEPHROS INC - Common Stock - $0.001 par value (NEPH)
CUSIP: 640671400
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock - $0.001 par value
- Shares outstanding
- 10,630,964
- Total 13F shares
- 4,502,818
- Share change
- +129,327
- Total reported value
- $37,780,000
- Price per share
- $8.39
- Number of holders
- 17
- Value change
- +$1,367,226
- Number of buys
- 6
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 640671400?
CUSIP 640671400 identifies NEPH - NEPHROS INC - Common Stock - $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640671400:
Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
|
Company |
32%
|
3,395,579
|
$21,391,000 | — | 31 Mar 2020 | |
| BARD ASSOCIATES INC |
13F
|
Company |
2%
|
207,569
|
$2,640,000 | — | 31 Mar 2020 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
2.4%
|
251,366
|
$1,584,000 | — | 31 Mar 2020 | |
| Cowen Prime Services LLC |
13F
|
Company |
1.5%
|
154,800
|
$975,000 | — | 31 Mar 2020 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
1.3%
|
133,140
|
$839,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.53%
|
56,737
|
$357,000 | — | 31 Mar 2020 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.41%
|
43,210
|
$273,000 | — | 31 Mar 2020 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.37%
|
39,863
|
$251,000 | — | 31 Mar 2020 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.32%
|
34,249
|
$216,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
20,012
|
$122,000 | — | 31 Mar 2020 | |
| B. Riley Wealth Advisors, Inc. |
13F
|
Company |
0.14%
|
14,428
|
$91,000 | — | 31 Mar 2020 | |
| ELKHORN PARTNERS LIMITED PARTNERSHIP |
13F
|
Company |
0.12%
|
12,957
|
$82,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.08%
|
8,659
|
$54,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
3,815
|
$24,000 | — | 31 Mar 2020 | |
| Sowell Financial Services LLC |
13F
|
Company |
0%
|
489
|
$3,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
481
|
$3,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
405
|
$2,000 | — | 31 Mar 2020 | |
| Claraphi Advisory Network, LLC |
13F
|
Company |
0%
|
388
|
$2,000 | — | 31 Mar 2020 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
367
|
$2,000 | — | 31 Mar 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
282
|
$2,000 | — | 31 Mar 2020 |
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q2 2020
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.